1 |
Pantoni L . Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol, 2010, 9: 689- 701.
doi: 10.1016/S1474-4422(10)70104-6
|
2 |
Wardlaw JM , Chabriat H , de Leeuw FE , Debette S , Dichgans M , Doubal F , Jokinen H , Katsanos AH , Ornello R , Pantoni L , Pasi M , Pavlovic AM , Rudilosso S , Schmidt R , Staals J , Taylor-Rowan M , Hussain S , Lindgren AG . European Stroke Organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke. Eur Stroke J, 2024, 9: 5- 68.
doi: 10.1177/23969873231219416
|
3 |
Markus HS , van Der Flier WM , Smith EE , Bath P , Biessels GJ , Briceno E , Brodtman A , Chabriat H , Chen C , de Leeuw FE , Egle M , Ganesh A , Georgakis MK , Gottesman RF , Kwon S , Launer L , Mok V , O'Brien J , Ottenhoff L , Pendlebury S , Richard E , Sachdev P , Schmidt R , Springer M , Tiedt S , Wardlaw JM , Verdelho A , Webb A , Werring D , Duering M , Levine D , Dichgans M . Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): a review. JAMA Neurol, 2022, 79: 1187- 1198.
doi: 10.1001/jamaneurol.2022.2262
|
4 |
Han F , Zhang DD , Zhai FF , Xue J , Zhang JT , Yan S , Zhou LX , Ni J , Yao M , Yang M , Li ML , Jin ZY , Dai Q , Zhang SY , Cui LY , Zhu YC . Association between large artery stenosis, cerebral small vessel disease and risk of ischemic stroke. Sci China Life Sci, 2021, 64: 1473- 1480.
doi: 10.1007/s11427-020-1849-x
|
5 |
Zeestraten EA , Lawrence AJ , Lambert C , Benjamin P , Brookes RL , Mackinnon AD , Morris RG , Barrick TR , Markus HS . Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease. Neurology, 2017, 89: 1869- 1876.
doi: 10.1212/WNL.0000000000004594
|
6 |
Clancy U , Arteaga-Reyes C , Jaime Garcia D , Hewins W , Locherty R , Valdés Hernández MDC , Wiseman SJ , Stringer MS , Thrippleton M , Chappell FM , Jochems ACC , Liu X , Cheng Y , Zhang J , Rudilosso S , Kampaite A , Hamilton OKL , Brown R , Bastin ME , Muñoz Maniega S , Hamilton I , Job D , Doubal FN , Wardlaw JM . Incident infarcts in patients with stroke and cerebral small vessel disease: frequency and relation to clinical outcomes. Neurology, 2024, 103: e209750.
doi: 10.1212/WNL.0000000000209750
|
7 |
Duering M , Biessels GJ , Brodtmann A , Chen C , Cordonnier C , de Leeuw FE , Debette S , Frayne R , Jouvent E , Rost NS , Ter Telgte A , Al-Shahi Salman R , Backes WH , Bae HJ , Brown R , Chabriat H , De Luca A , deCarli C , Dewenter A , Doubal FN , Ewers M , Field TS , Ganesh A , Greenberg S , Helmer KG , Hilal S , Jochems ACC , Jokinen H , Kuijf H , Lam BYK , Lebenberg J , MacIntosh BJ , Maillard P , Mok VCT , Pantoni L , Rudilosso S , Satizabal CL , Schirmer MD , Schmidt R , Smith C , Staals J , Thrippleton MJ , van Veluw SJ , Vemuri P , Wang Y , Werring D , Zedde M , Akinyemi RO , Del Brutto OH , Markus HS , Zhu YC , Smith EE , Dichgans M , Wardlaw JM . Neuroimaging standards for research into small vessel disease: advances since 2013. Lancet Neurol, 2023, 22: 602- 618.
doi: 10.1016/S1474-4422(23)00131-X
|
8 |
Sleight E , Stringer MS , Clancy U , Arteaga-Reyes C , Jaime Garcia D , Jochems ACC , Wiseman S , Valdes Hernandez M , Chappell FM , Doubal FN , Marshall I , Thrippleton MJ , Wardlaw JM . Association of cerebrovascular reactivity with 1-year imaging and clinical outcomes in small vessel disease: an observational cohort study. Neurology, 2024, 103: e210008.
doi: 10.1212/WNL.0000000000210008
|
9 |
Brown RB , Tozer DJ , Loubière L , Harshfield EL , Hong YT , Fryer TD , Williams GB , Graves MJ , Aigbirhio FI , O'Brien JT , Markus HS . Minocycline to reduce inflammation and blood-brain barrier leakage in small vessel disease (MINERVA): a phase Ⅱ, randomized, double-blind, placebo-controlled experimental medicine trial. Alzheimers Dement, 2024, 20: 3852- 3863.
doi: 10.1002/alz.13830
|
10 |
Duering M , Konieczny MJ , Tiedt S , Baykara E , Tuladhar AM , Leijsen EV , Lyrer P , Engelter ST , Gesierich B , Achmüller M , Barro C , Adam R , Ewers M , Dichgans M , Kuhle J , de Leeuw FE , Peters N . Serum neurofilament light chain levels are related to small vessel disease burden. J Stroke, 2018, 20: 228- 238.
doi: 10.5853/jos.2017.02565
|
11 |
Kremer R , Williams A , Wardlaw J . Endothelial cells as key players in cerebral small vessel disease. Nat Rev Neurosci, 2025, 26: 179- 188.
doi: 10.1038/s41583-024-00892-0
|
12 |
SPS3 Study Group , Benavente OR , Coffey CS , Conwit R , Hart RG , McClure LA , Pearce LA , Pergola PE , Szychowski JM . Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet, 2013, 382: 507- 515.
doi: 10.1016/S0140-6736(13)60852-1
|
13 |
de Havenon A , Sheth KN , Madsen TE , Johnston KC , Turan TN , Toyoda K , Elm JJ , Wardlaw JM , Johnston SC , Williams OA , Shoamanesh A , Lansberg MG . Cilostazol for secondary stroke prevention: history, evidence, limitations, and possibilities. Stroke, 2021, 52: e635- e645.
|
14 |
Kopczak A , Stringer MS , van den Brink H , Kerkhofs D , Blair GW , van Dinther M , Reyes CA , Garcia DJ , Onkenhout L , Wartolowska KA , Thrippleton MJ , Kampaite A , Duering M , Staals J , Lesnik-Oberstein S , Muir KW , Middeke M , Norrving B , Bousser MG , Mansmann U , Rothwell PM , Doubal FN , van Oostenbrugge R , Biessels GJ , Webb AJS , Wardlaw JM , Dichgans M , TREAT-SVDs Collaborators . Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial. Lancet Neurol, 2023, 22: 991- 1004.
doi: 10.1016/S1474-4422(23)00293-4
|
15 |
Webb AJS , Birks JS , Feakins KA , Lawson A , Dawson J , Rothman AMK , Werring DJ , Llwyd O , Stewart CR , Thomas J . Cerebrovascular effects of sildenafil in small vessel disease: the OxHARP trial. Circ Res, 2024, 135: 320- 331.
doi: 10.1161/CIRCRESAHA.124.324327
|
16 |
Wardlaw JM , Woodhouse LJ , Mhlanga Ⅱ , Oatey K , Heye AK , Bamford J , Cvoro V , Doubal FN , England T , Hassan A , Montgomery A , O'Brien JT , Roffe C , Sprigg N , Werring DJ , Bath PM , Lacunar Intervention Trial-2 (LACI-2) Investigator Group . Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the Lacunar Intervention Trial-2 (LACI-2) randomized clinical trial. JAMA Neurol, 2023, 80: 682- 692.
doi: 10.1001/jamaneurol.2023.1526
|
17 |
Yang XZ , Huang MY , Han F , Ni J , Zhou LX , Yao M , Zhang DD , Zhu YC . Genome-wide Mendelian randomization study reveals druggable genes for cerebral small vessel disease. Stroke, 2024, 55: 2264- 2273.
doi: 10.1161/STROKEAHA.124.046544
|
18 |
Adaptive Platform Trials Coalition . Adaptive platform trials: definition, design, conduct and reporting considerations. Nat Rev Drug Discov, 2019, 18: 797- 807.
doi: 10.1038/s41573-019-0034-3
|
19 |
Gregson J , Donners SJA , Dippel D , Lingsma H , Dea Hazewinkel A , Brown MM , Bonati LH , Nederkoorn PJ . Use of the win ratio for analysis of stroke trials: description, illustration, and planned use in the Second European Carotid Surgery Trial (ECST-2). Stroke, 2025, 56: 230- 238.
doi: 10.1161/STROKEAHA.124.048689
|
20 |
Kosiborod MN , Petrie MC , Borlaug BA , Butler J , Davies MJ , Hovingh GK , Kitzman DW , Møller DV , Treppendahl MB , Verma S , Jensen TJ , Liisberg K , Lindegaard ML , Abhayaratna W , Ahmed FZ , Ben-Gal T , Chopra V , Ezekowitz JA , Fu M , Ito H , Lelonek M , Melenovský V , Merkely B , Núñez J , Perna E , Schou M , Senni M , Sharma K , van der Meer P , Von Lewinski D , Wolf D , Shah SJ , STEP-HFpEF DM Trial Committees and Investigators . Semaglutide in patients with obesity-related heart failure and type 2 diabetes. N Engl J Med, 2024, 390: 1394- 1407.
doi: 10.1056/NEJMoa2313917
|